Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Brenner tumors: single centre experience
1Department of Gynecologic Oncology, Tepecik Training and Research Hospital, 35080 Izmir, Turkey
2Department of Pathology, Tepecik Training and Research Hospital, 35080 Izmir, Turkey
3Department of Gynecology and Obstetric, Tepecik Training and Research Hospital, 35080 Izmir, Turkey
DOI: 10.22514/ejgo.2024.055 Vol.45,Issue 3,June 2024 pp.122-129
Submitted: 29 January 2024 Accepted: 05 March 2024
Published: 15 June 2024
*Corresponding Author(s): Özgür Erdoğan E-mail: ozgrerd@gmail.com
The objective of this study was to assess the clinical and pathological characteristics, as well as the oncological outcomes, of Brenner tumors (BTs). The assessment was conducted on the information of 63 patients diagnosed with Brenner Tumor, which was obtained from both the oncology clinic database and pathology reports spanning the time period from 2002 to 2022. The patients’ ages in the study had a median of 57 years, ranging from 43 to 83 years. Median (range) tumor size was 10 (0.75–165) mm. Out of the total number of patients, 60 individuals (95.2%) had benign tumors, while the remaining 3 (4.8%) were diagnosed with malign tumors. No borderline tumors were detected among the patients. A mixed tumor, comprising both a borderline tumor and other ovarian pathology, was found in 7 cases, accounting for 11.1%. Brenner tumors are infrequent and typically identified coincidentally. Malign Brenner Tumors (MBTs) receive similar management as epithelial neoplasms. Given the uncommon nature of these tumors, the appropriateness of lymphadenectomy and optimal chemotherapy protocols remains a subject of debate.
Ovarian Brenner tumors; Rare tumors of ovary; Ovarian malignancies
Özgür Erdoğan,Celal Akdemir,Ayşe Gül Besler,Emel Doğan Özdaş,Serkan Karaoğlu,Duygu Ayaz,Esin Kasap,Muzaffer Sanci. Brenner tumors: single centre experience. European Journal of Gynaecological Oncology. 2024. 45(3);122-129.
[1] Zheng R, Heller DS. Borderline Brenner tumor: a review of the literature. Archives of Pathology & Laboratory Medicine. 2019; 143: 1278–1280.
[2] Borah T, Mahanta RK, Bora BD, Saikia S. Brenner tumor of ovary: an incidental finding. Journal of Mid-life Health. 2011; 2: 40–41.
[3] Lang SM, Mills AM, Cantrell LA. Malignant Brenner tumor of the ovary: review and case report. Gynecologic Oncology Reports. 2017; 22: 26–31.
[4] Höhn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn L. 2020 WHO classification of female genital tumors. Geburtshilfe Und Frauenheilkunde. 2021; 81: 1145–1153.
[5] Eble J, Tavassoli F, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. 2003. Available at: https://books.google.com/books?hl=tr&lr=&id=gYMlMcE1-bsC&oi=fnd&pg=PA214&dq=Eble+JN,+Tavassoli+FA,+Devilee+P.+Pathology+and+genetics+of+tumours+of+the+breast+and+female+genital+organs:+Iarc+Press%3B+2003&ots=nbQtgEIOQ-&sig=jOXax87Xy5DcpTUN8IILyGspf5A (Accessed: 13 August 2023).
[6] Ziadi S, Trimeche M, Hammedi F, Hidar S, Sriha B, Mestiri S, et al. Bilateral proliferating Brenner tumor of the ovary associated with recurrent urothelial carcinoma of the urinary bladder. North American Journal of Medical Sciences. 2010; 2: 39–41.
[7] Ehrlich CE, Roth LM. The Brenner tumor. A clinicopathologic study of 57 cases. Cancer. 1971; 27: 332–342.
[8] Zhang Y, Staley SA, Tucker K, Clark LH. Malignant Brenner tumor of the ovary: case series and review of treatment strategies. Gynecologic Oncology Reports. 2019; 28: 29–32.
[9] Varden Lc. Bılateral Brenner tumors of the ovaries. A brief revıew of the literature with report of a case. Medical Annals of the District of Columbia. 1964; 33: 70–73.
[10] Gifford RR, Birch HW. Bilateral Brenner tumors of the ovary. Journal of the Medical Association of Georgia. 1969; 58: 145–151.
[11] Farrar HK, Greene RR. Bilateral Brenner tumors of the ovary. American Journal of Obstetrics and Gynecology. 1960; 80: 1089–1095.
[12] Yüksel D, Kılıç C, Çakır C, Kimyon Cömert G, Turan T, Ünlübilgin E, et al. Brenner tumors of the ovary: clinical features and outcomes in a single-center cohort. Journal of the Turkish-German Gynecological Association. 2022; 23: 22–27.
[13] Green GE, Mortele KJ, Glickman JN, Benson CB. Brenner tumors of the ovary. Journal of Ultrasound in Medicine. 2006; 25: 1245–1251.
[14] Ruggiero S, Ripetti V, Bianchi A, La Vaccara V, Alloni R, Coppola R. A singular observation of a giant benign Brenner tumor of the ovary. Archives of Gynecology and Obstetrics. 2011; 284: 513–516.
[15] Nasioudis D, Sisti G, Holcomb K, Kanninen T, Witkin SS. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecologic Oncology. 2016; 142: 44–49.
[16] Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Duvillard P, Darai E, et al. Management and prognosis of borderline ovarian Brenner tumors. International Journal of Gynecologic Cancer. 2012; 22: 1332–1336.
[17] Roma AA, Masand RP. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Annals of Diagnostic Pathology. 2015; 19: 29–32.
[18] Waxman M. Pure and mixed Brenner tumors of the ovary: clinicopathologic and histogenetic observations. Cancer. 1979; 43: 1830–1839.
[19] Kondi-Pafiti A, Kairi-Vassilatou E, Iavazzo C, Vouza E, Mavrigiannaki P, Kleanthis C, et al. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors. Archives of Gynecology and Obstetrics. 2012; 285: 1699–1702.
[20] Alloush F, Bahmad HF, Lutz B, Poppiti R, Recine M, Alghamdi S, et al. Brenner tumor of the ovary: a 10-year single institution experience and comprehensive review of the literature. Medical Sciences. 2023; 11: 18.
[21] Nazari F, Dehghani Z. Coexistence of benign Brenner tumor with mucinous cystadenoma in an ovarian mass. Iranian Journal of Pathology. 2020; 15: 334–337.
[22] Wang Y, Wu R, Shwartz LE, Haley L, Lin M, Shih I, et al. Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin. The Journal of Pathology. 2015; 237: 146–151.
[23] Mallya V, Sharma M, Khangar B, Khurana N, Gupta S. Coexisting Brenner tumor and endometrial carcinoma. Journal of Mid-life Health. 2017; 8: 89–91.
[24] Matlock DL, Salem FA, Charles EH, Savage EW. Synchronous multiple primary neoplasms of the upper female genital tract. Gynecologic Oncology. 1982; 13: 271–277.
[25] Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of the female reproductive organs (IARC WHO Classification of Tumours). World Health Organization. 2014; 1–309.
[26] Gezginç K, Karatayli R, Yazici F, Acar A, Çelik Ç, Çapar M, et al. Malignant Brenner tumor of the ovary: analysis of 13 cases. International Journal of Clinical Oncology. 2012; 17: 324–329.
[27] Han J, Kim D, Lee S, Park J, Kim J, Kim Y, et al. Intensive systemic chemotherapy is effective against recurrent malignant Brenner tumor of the ovary: an analysis of 10 cases within a single center. Taiwanese Journal of Obstetrics and Gynecology. 2015; 54: 178–182.
[28] Nasioudis D, Sisti G, Holcomb K, Kanninen T, Witkin SS. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecologic Oncology. 2016; 142: 44–49.
Top